Literature DB >> 1995740

Antiborrelial activity of serum from rats injected with the Lyme disease spirochete.

C S Pavia1, V Kissel, S Bittker, F Cabello, S Levine.   

Abstract

The functional properties of humoral factors generated in rats immunized against Borrelia burgdorferi were investigated. After Lewis strain rats were injected intraperitoneally with live B. burgdorferi or in the footpad with dead borreliae incorporated in complete Freund's adjuvant, they produced high-titered antisera. At a dilution of less than or equal to 1:10, sera from immunized or infected rats but not control sera inhibited growth of B. burgdorferi in vitro. Neutralization of growth of three different strains of B. burgdorferi by posttreatment sera was dose-dependent and was detected equally well by direct microscopic counts or by measuring incorporation of tritiated adenine into newly synthesized nucleic acids. These findings provide direct evidence that infection or immunization with the Lyme disease spirochete induces the formation of serum factors capable of preventing the growth of B. burgdorferi in vitro.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1995740     DOI: 10.1093/infdis/163.3.656

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Failure of topical antibiotics to prevent disseminated Borrelia burgdorferi infection following a tick bite in C3H/HeJ mice.

Authors:  Gary P Wormser; Thomas J Daniels; Susan Bittker; Denise Cooper; Guiqing Wang; Charles S Pavia
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  In vitro assessment of antiborrelial activity of OspA vaccine sera.

Authors:  Paul T Fawcett; Carlos D Rose; Kathleen M Gibney
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

3.  Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferi.

Authors:  J L Schmitz; S D Lovrich; S M Callister; R F Schell
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

4.  Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.

Authors:  J Ma; C Gingrich-Baker; P M Franchi; P Bulger; R T Coughlin
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

Review 5.  Lyme disease vaccine.

Authors:  G P Wormser
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

Review 6.  Experimental immunization against Lyme borreliosis with recombinant Osp proteins: an overview.

Authors:  A Sadziene; A G Barbour
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

7.  Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae).

Authors:  K Kurtenbach; A Dizij; H M Seitz; G Margos; S E Moter; M D Kramer; R Wallich; U E Schaible; M M Simon
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies.

Authors:  M Scriba; J S Ebrahim; T Schlott; H Eiffert
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi.

Authors:  R K Straubinger; Y F Chang; R H Jacobson; M J Appel
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

10.  Lyme disease assay which detects killed Borrelia burgdorferi.

Authors:  S M Callister; R F Schell; S D Lovrich
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.